Download this PDF file
Crossref Citations
1. Neuropsychiatric Complications of Efavirenz in Children With HIV Infection
Charles K Hammond, Brian Eley, Jo M Wilmshurst
Future Virology vol: 11 issue: 6 first page: 469 year: 2016
doi: 10.2217/fvl-2016-0030
2. Recent Advances in Drug Delivery Strategies for Improved Therapeutic Efficacy of Efavirenz
Mitali Patel, Ruhi Shah, Krutika Sawant
Recent Patents on Nanotechnology vol: 14 issue: 2 first page: 119 year: 2020
doi: 10.2174/1872210513666191019103129
3. Antiviral drugs in aquatic environment and wastewater treatment plants: A review on occurrence, fate, removal and ecotoxicity
Christina Nannou, Anna Ofrydopoulou, Eleni Evgenidou, David Heath, Ester Heath, Dimitra Lambropoulou
Science of The Total Environment vol: 699 first page: 134322 year: 2020
doi: 10.1016/j.scitotenv.2019.134322
4. Development and Validation of RP-Chiral HPLC Method for Determination of (R)-Enantiomer Excess Content in Efavirenz
CH. RAMESH, DHARMASOTH RAMA DEVI DEVI, M.N.B. SRINIVAS, S. RADHA KRISHNA, NAGARAJU RAJANA, K. BASAVAIAH
Asian Journal of Chemistry vol: 32 issue: 9 first page: 2208 year: 2020
doi: 10.14233/ajchem.2020.22755
5. Solvent Effect on The Equilibrium and Rate Constant of the Tautomeric Reaction in Nexium, Skelaxin, Aldara and Efavirenz Drugs: A Dft Study
M. Sargolzaei, M. Afshar, H. Nikoofard
Journal of Structural Chemistry vol: 59 issue: 2 first page: 297 year: 2018
doi: 10.1134/S0022476618020063
6. Reported ADRs of efavirenz-based antiretroviral drugs among outpatients attending sexually transmitted infections clinic in a tertiary health facility in Northern Nigeria
Umar Muhammad Tukur, Balarabe Adamu Isah
National Journal of Pharmacology and Therapeutics vol: 1 issue: 3 first page: 133 year: 2023
doi: 10.4103/NJPT.NJPT_35_23